Natus Research Development from 2010 to 2026
| NM4 Stock | EUR 0.22 0.02 8.33% |
Research Development | First Reported 2016-12-31 | Previous Quarter 13.8 M | Current Value 13.2 M | Quarterly Volatility 1.7 M |
Check Natus Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Natus Medical's main balance sheet or income statement drivers, such as Interest Expense of 9 M, Selling General Administrative of 181.6 M or Total Revenue of 321.4 M, as well as many indicators such as . Natus financial statements analysis is a perfect complement when working with Natus Medical Valuation or Volatility modules.
Natus | Research Development |
The Research Development trend for Natus Medical Incorporated offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Natus Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Natus Medical's Research Development Growth Pattern
Below is the plot of the Research Development of Natus Medical Incorporated over the last few years. It is Natus Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Natus Medical's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Natus Research Development Regression Statistics
| Arithmetic Mean | 46,496,065 | |
| Geometric Mean | 44,341,304 | |
| Coefficient Of Variation | 30.18 | |
| Mean Deviation | 13,070,053 | |
| Median | 52,747,200 | |
| Standard Deviation | 14,034,652 | |
| Sample Variance | 197T | |
| Range | 34.7M | |
| R-Value | 0.84 | |
| Mean Square Error | 60.4T | |
| R-Squared | 0.71 | |
| Significance | 0.000021 | |
| Slope | 2,345,745 | |
| Total Sum of Squares | 3151.5T |
Natus Research Development History
About Natus Medical Financial Statements
Natus Medical stakeholders use historical fundamental indicators, such as Natus Medical's Research Development, to determine how well the company is positioned to perform in the future. Although Natus Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Natus Medical's assets and liabilities are reflected in the revenues and expenses on Natus Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Natus Medical Incorporated. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 64.8 M | 52.7 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Natus Stock
Natus Medical financial ratios help investors to determine whether Natus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Natus with respect to the benefits of owning Natus Medical security.